FDA official logo
GSRS logo
PFDA official logo

MAGROLIMAB

  • UNII: 90YIEHRFJ9
  • Preferred Substance Name: MAGROLIMAB

  • 2169232-81-7
  • ANTI-CD47 MONOCLONAL ANTIBODY HU5F9-G4
  • HU5F9 G4 [WHO-DD]
  • HU5F9-G4
  • IMMUNOGLOBULIN G4(225-PROLINE), ANTI-(HUMAN CD47 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL HU5F9-G4 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL HU5F9-G4 .KAPPA.-CHAIN, DIMER
  • IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS CD47 (INTEGRIN ASSOCIATED PROTEIN, IAP, MER6, OA3)), MONOCLONAL ANTIBODYGAMMA4 HEAVY CHAIN (1-444) (VH (HOMO SAPIENS IGHV1-3*01 (87.8%)-(IGHD)-IGHJ4*01 (100%)) (8.8.10) (1-117)-HOMO SAPIENS IGHG4*01 (CH1 (118-215), HINGE S10>P (225) (216-227), CH2 (228-337), CH3 (338-442), CHS (443-444)) (118-444)), (131-219')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-219') (V-KAPPA (MUS MUSCULUS IGKV1-117*01 (89.0%)-IGKJ2*03 (91.7%)/HOMO SAPIENS IGKV2-28*01 (86%)-IGKJ2*01 (100%)) (11.3.9) (1'-112')-HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (158), V101 (196) (113'-219'))DIMER (223-223'':226-226'')-BISDISULFIDE
  • MAGROLIMAB [INN]
  • MAGROLIMAB [USAN]
  • MAGROLIMAB [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.